Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Fuchs, Michael A ^a   Sato, Kaori ^b   Niedzwiecki, Donna ^c   Ye, Xing ^c   Saltz, Leonard B ^d   Mayer, Robert J ^b   Mowat, Rex B ^e   Whittom, Renaud ^f   Hantel, Alexander ^g   Benson, Al ^h   Atienza, Daniel ⁱ   Messino, Michael ^j   Kindler, Hedy ^k   Venook, Alan ^l   Ogino, Shuji ^b,m   Wu, Kana ⁿ   Willett, Walter C ⁿ   Giovannucci, Edward L ^m,n   Meyerhardt, Jeffrey A ^b  

^a BROWN UNIVERSITY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e Toledo Community Hospital Oncology Program   (United States)

^f HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^g LOYOLA UNIVERSITY CHICAGO   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ Virginia Oncology Associates   (United States)

^j Mission Hospital   (United States)

^k UNIVERSITY OF CHICAGO   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁿ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; SUGAR; SUGAR INTAKE; SWEETENING AGENT;

ADULT; AGED; ARTICLE; BEVERAGE; BODY MASS; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DISEASE ASSOCIATION; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HAZARD RATIO; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC EQUIVALENT; OBESITY; PHYSICAL ACTIVITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SUGAR SWEETENED BEVERAGE; VERY ELDERLY; ADVERSE EFFECTS; COLON TUMOR; ETIOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK FACTOR; SUGAR INTAKE; TUMOR RECURRENCE; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BEVERAGES; COLONIC NEOPLASMS; DIETARY SUCROSE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SWEETENING AGENTS; YOUNG ADULT;

EID: 84903267969     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099816     Document Type: Article

References (48)

1. Giovannucci E (2003) Diet, body weight, and colorectal cancer: a summary of the epidemiologic evidence. J Womens Health (Larchmt) 12: 173-182.
2. Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 16: 2533-2547. (Pubitemid 351196307)
3. Samad AK, Taylor RS, Marshall T, Chapman MA (2005) A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis 7: 204-213. (Pubitemid 40637417)
4. Chan AT, Giovannucci EL (2010) Primary prevention of colorectal cancer. Gastroenterology 138: 2029-2043 e2010.
5. Giovannucci E (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131: 3109S-3120S.
6. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, et al. (2000) Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92: 1592-1600.
7. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, et al. (1999) Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91: 1147-1154. (Pubitemid 29330553)
8. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, et al. (2005) A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 14: 850-855. (Pubitemid 40478547)
9. Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, et al. (2012) The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev 21: 1244-1259.
10. Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Hu FB, et al. (2007) Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. Jama 298: 754-764. (Pubitemid 47263158)
11. Wolpin BM, Meyerhardt JA, Chan AT, Ng K, Chan JA, et al. (2009) Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol 27: 176-185.
12. Hu FB, Malik VS (2010) Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence. Physiol Behav 100: 47-54.
13. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, et al. (2004) Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. Jama 292: 927-934. (Pubitemid 39097202)
14. Malik VS, Schulze MB, Hu FB (2006) Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr 84: 274-288. (Pubitemid 44699135)
15. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB (2011) Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 364: 2392-2404.
16. Vartanian LR, Schwartz MB, Brownell KD (2007) Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am J Public Health 97: 667-675. (Pubitemid 47280164)
17. Malik VS, Hu FB (2011) Sugar-sweetened beverages and health: where does the evidence stand? Am J Clin Nutr 94: 1161-1162.
18. Andreyeva T, Chaloupka FJ, Brownell KD (2011) Estimating the potential of taxes on sugar-sweetened beverages to reduce consumption and generate revenue. Prev Med 52: 413-416.
19. Singh GM, Micha R, Katibzadeh S, Lim S, Ezzati M, et al. (2013) 180,000 deaths worldwide may be associated with sugary soft drinks. Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism 2013 New Orleans. pp. MP22.
20. Saltz LB, Niedzwiecki D, Hollis D, Goldberg RM, Hantel A, et al. (2007) Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803. J Clin Oncol 25: 3456-3461. (Pubitemid 47310883)
21. Zubrod C, Scheiderman M, Frei E. (1960) Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 11: 7-33.
22. Meyerhardt JA, Sato K, Niedzwiecki D, Ye C, Saltz LB, et al. (2012) Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst 104: 1702-1711.
23. Willett WC, Reynolds RD, Cottrell-Hoehner S, Sampson L, Browne ML (1987) Validation of a semi-quantitative food frequency questionnaire: comparison with a 1-year diet record. J Am Diet Assoc 87: 43-47. (Pubitemid 17000788)
24. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, et al. (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122: 51-65. (Pubitemid 15010435)
25. Agriculture UDo (1989) Composition of foods - raw, processed, and prepared, 1963-1988. Agriculture handbook no. 8 series. Washington, D.C. Department of Agriculture, US Government Printing Office.
26. Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124: 17-27. (Pubitemid 16095831)
27. Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, et al. (1989) Food-based validation of a dietary questionnaire: the effects of week- to-week variation in food consumption. Int J Epidemiol 18: 858-867. (Pubitemid 20030201)
28. Meyerhardt JA, Heseltine D, Campos H, Holmes MD, Willett WC, et al. (2005) Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy. J Clin Oncol 23: 8453-8460.
29. Meyerhardt JA, Fuchs C (2007) Cancer Recurrence and Survival Associated With Dietary Patterns in Stage III Colon Cancer-Reply Jama 298: 2263.
30. Cox D (1972) Regression models and life tables. J R Stat Soc B 34: 187-220.
31. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Jr., Montoye HJ, et al. (1993) Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25: 71-80. (Pubitemid 23027685)
32. Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, et al. (2013) Associations between dietary and lifestyle risk factors and colorectal cancer in the Scottish population. Eur J Cancer Prev.
33. Zhang X, Albanes D, Beeson WL, van den Brandt PA, Buring JE, et al. (2010) Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. J Natl Cancer Inst 102: 771-783.
34. Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, et al. (2010) Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 33: 2477-2483.
35. Choi HK, Willett W, Curhan G (2010) Fructose-rich beverages and risk of gout in women. Jama 304: 2270-2278.
36. de Ruyter JC, Olthof MR, Kuijper LD, Katan MB (2012) Effect of sugar-sweetened beverages on body weight in children: design and baseline characteristics of the Double-blind, Randomized INtervention study in Kids. Contemp Clin Trials 33: 247-257.
37. Ebbeling CB, Feldman HA, Chomitz VR, Antonelli TA, Gortmaker SL, et al. (2012) A randomized trial of sugar-sweetened beverages and adolescent body weight. N Engl J Med 367: 1407-1416.
38. Qi Q, Chu AY, Kang JH, Jensen MK, Curhan GC, et al. (2012) Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med 367: 1387-1396.
39. Pollak MN, Perdue JF, Margolese RG, Baer K, Richard M (1987) Presence of somatomedin receptors on primary human breast and colon carcinomas. Cancer Lett 38: 223-230. (Pubitemid 18005853)
40. Watkins L, Lewis L, Levine A (1990) Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. Int J Cancer 45: 372-375. (Pubitemid 20061396)
41. Koenuma M, Yamori T, Tsuruo T (1989) Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 80: 51-58. (Pubitemid 20027198)
42. Bjork J, Nilsson J, Hultcrantz R, Johansson C (1993) Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol 28: 879-884. (Pubitemid 23294761)
43. Mattes RD (1996) Dietary compensation by humans for supplemental energy provided as ethanol or carbohydrate in fluids. Physiol Behav 59: 179-187.
44. DiMeglio DP, Mattes RD (2000) Liquid versus solid carbohydrate: effects on food intake and body weight. Int J Obes Relat Metab Disord 24: 794-800. (Pubitemid 30339280)
45. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, et al. (2009) Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119: 1322-1334.
46. Michaud DS, Fuchs CS, Liu S, Willett WC, Colditz GA, et al. (2005) Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 14: 138-147.
47. Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, et al. (2006) Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 24: 3535-3541. (Pubitemid 46630523)
48. Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, et al. (2008) Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol 26: 4109-4115.